Peter L. Levin

Conversa is a leader in automated virtual health at scale. Conversa’s Automated Virtual Care and Triage™ platform utilizes its proprietary patient profiling and health signals engine, and an extensive library of evidence-based automated Conversational Care™ pathways, to help healthcare organizations effectively and efficiently risk stratify and remotely manage patients across the care continuum. Leading health systems, payers, employers and pharmaceutical companies are using Conversa to develop meaningful relationships and drive better health outcomes.

Conversa is a leader in automated virtual health at scale. Conversa’s Automated Virtual Care and Triage™ platform utilizes its proprietary patient profiling and health signals engine, and an extensive library of evidence-based automated Conversational Care™ pathways, to help healthcare organizations effectively and efficiently risk stratify and remotely manage patients across the care continuum. Leading health systems, payers, employers and pharmaceutical companies are using Conversa to develop meaningful relationships and drive better health outcomes.

Amida Technology Solutions, Inc. (Amida) is a software services company that solves the most complex challenges in data interoperability, data exchange, data governance, and data security. We create and manage solutions that enable the reliable exchange of sensitive information — from conception through deployment. Amida securely develops and configures data resources for our clients, which include federal, state, and commercial enterprises. We build custom, open-source solutions that collect and prepare data from a variety of sources – independent of structure, format, provenance, and schema – for applications like business intelligence, predictive analytics (including AL, ML, and NLP), and downstream transactions. Additionally, we help select, configure, and run commercial-off-the-shelf applications for our clients. We are especially known for open data architectures and production services that are scalable, efficient, modular, and secure. Our software engineers and data scientists have extensive knowledge in data modeling, reconciliation, administration, and visualization – with vast experience in health IT.

DAFCA is a company focused on post-silicon SoC validation, debug, and in-system bring-up. DAFCA's tools allow design teams to seamlessly incorporate our patented and compact reconfigurable instrumentation IP into their devices, pre-silicon, in order to observe, discover, and diagnose at-speed, in-silicon functional behavior.

TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics. The TVM investment team has worked together for over a decade to effectively utilize this innovative approach to maximize returns for investors and finance new therapies and technologies to meaningfully improve patient lives.